SCHEMBL23148142

SCHEMBL23148142

Cc1cn(C2CC[Si](C)(C)CC2)c(C)c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23148114 0.94 — —
SCHEMBL23147927 0.62 KCNH2 (0.31) —
SCHEMBL23148165 0.58 — —
SCHEMBL23148110 0.57 — —
SCHEMBL23148101 0.56 USP2 (0.30) —
SCHEMBL23147881 0.56 — —
SCHEMBL19428176 0.50 — —
SCHEMBL820464 0.49 — —
SCHEMBL14275883 0.48 — —
SCHEMBL19428196 0.45 KDM4E (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021062316-A1 AZAINDOLE CARBOXAMIDE COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. (US) 2021-04-01 — — WO disclosed
Send feedback